Tag: Parkinson’s disease (PD)

Letter to the Editor: Antipsychotics and Parkinson’s Disease: A Troubling Mix

Letter to the Editor: Antipsychotics and Parkinson’s Disease: A Troubling Mix

| March 1, 2023

Funding/financial disclosures. The authors have no conflict of interest relevant to the content of this letter. Our studies are supported by the following grants: Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES). Innov Clin […]

Continue Reading

Palmitoylethanolamide/Luteolin as Adjuvant Therapy to Improve an Unusual Case of Camptocormia in a Patient with Parkinson’s Disease:  A Case Report

Palmitoylethanolamide/Luteolin as Adjuvant Therapy to Improve an Unusual Case of Camptocormia in a Patient with Parkinson’s Disease: A Case Report

| October 1, 2021

by Stefania Brotini, MD Dr. Brotini is with the Movement Disorder Center, Department of Neurology, San Giuseppe Hospital in Empoli, Florence, Italy FUNDING: No funding was provided for this study.  DISCLOSURES: The author has no conflicts of interest relevant to the content of this article.  Innov Clin Neurosci. 2021;18(10–12):12–14. ABSTRACT: Background. Camptocormia is a complication in […]

Continue Reading

Effects of Prismatic Lenses on Lateral Axial Dystonia in Parkinson’s Disease: A Pilot Study

Effects of Prismatic Lenses on Lateral Axial Dystonia in Parkinson’s Disease: A Pilot Study

| January 1, 2021

by Michele Meglio, PhD Student; Enrica Olivola, MD, PhD; Marco Santilli, BSC; Francesco Lena, MSC, PhD; Diego Centonze, MD, PhD; Matteo Bologna, MD, PhD; and Nicola Modugno, MD, PhD Dr. Meglio is with IRCCS Neuromed in the Unit of Neuro-Ophthalmology in Pozzilli, Italy; he’s a PhD student in Neuroscience at University of Rome Tor Vergata […]

Continue Reading